Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Astra Zeneca | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Astra Zeneca

Revenues drop 11%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Astra Zeneca

1Q Revenues: $7.3 billion (-11%)

1Q Earnings: $1.6 billion (-43%)

Comments: Loss of exclusivity on several key brands, mainly Seroquel IR, Nexium and Arimidex, accounted for 8% of revenue decline, which included a $223.0 million returns reserve against US trade inventories of Seroquel IR. Restructuring costs were $702.0 million in the quarter. U.S. revenues were down 12% impacted by generic competition. Revenue in the Rest of World was down 11%, with revenue declines in Brazil, Turkey and Mexico accounting for more than 40% of the shortfall. R&D expense increased 2% in the quarter.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters